• No results found

The formation of cysteine linked dimers of BST 2/tetherin is important for inhibition of HIV 1 virus release but not for sensitivity to Vpu

N/A
N/A
Protected

Academic year: 2020

Share "The formation of cysteine linked dimers of BST 2/tetherin is important for inhibition of HIV 1 virus release but not for sensitivity to Vpu"

Copied!
16
0
0

Loading.... (view fulltext now)

Full text

Figure

Figure 2 (see legend on next page)
Figure 3Immunoblot analysis of BST-2 glycosylation mutantsImmunoblot analysis of BST-2 glycosylation mutants
Figure 5cysteine-linked homo-dimerization of BST-2 is importantfor the inhibition of HIV-1 virus release
Figure 7releaseDimerization of BST-2 is important for inhibition of virus Dimerization of BST-2 is important for inhibition of virus release

References

Related documents

Регресійні моделі нормативних сонографічних параметрів щитоподібної залози в залежності від особливостей будови тіла у чоловіків і жінок різного віку = Regression

Therefore, we reviewed the effect of different intervention strategies to implement clinical guidelines at hospitals, and explored the impact of specific organisational factors on

The involvement of UL97 in cytoplasmic assembly and tegumentation steps is suggested by a unique combination of ultrastructural features formed exclusively in cells infected with ⌬

We also observed significant associations between the covarying cluster of eight HLA-independent polymorphisms and five of seven HLA-se- lected mutations in the NTD that have

We determined the crystal structures of the ectodomains of two FL1 mutants of herpes simplex virus type 1 (HSV-1) gB to clarify whether their fusion-null phenotypes were due to

IFN-induction dose-response curves (17, 18) were generated by exposing developmentally aged primary CECs (35, 36) to increasing amounts of the four candidate LAIVs derived

In the present study, we demonstrated that induction of TNF- ␣ expression in primary mouse astrocytes by MHV-A59 infection is mediated specifically through activation of the

We show that (i) a three-dose vaccination schedule with JE-VAX provides cross-protective immunity, albeit only partial in the more severe challenge model; (ii) a single dose